Vaxcyte Inc (PCVX)

Feb 20, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells $670,800.00 in Stock - MarketBeat

Feb 20, 2025

Feb 20, 2025

Vaxcyte Inc to Host Earnings Call - ACCESS Newswire

Feb 20, 2025

Feb 20, 2025

Vaxcyte president and CFO sells $670,822 in stock By Investing.com - Investing.com South Africa

Feb 20, 2025

Feb 20, 2025

State of New Jersey Common Pension Fund D Purchases 5,427 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Feb 20, 2025

Feb 19, 2025

Vaxcyte president and CFO sells $670,822 in stock - Investing.com India

Feb 19, 2025

Feb 19, 2025

Vaxcyte Executive Sells Shares Under Trading Plan - TradingView

Feb 19, 2025

Feb 19, 2025

Vaxcyte (PCVX) to Release Quarterly Earnings on Tuesday - MarketBeat

Feb 19, 2025

Feb 19, 2025

TimesSquare Capital Management LLC Boosts Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Feb 19, 2025

Feb 18, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) Stock Holdings Lowered by Banque Pictet & Cie SA - MarketBeat

Feb 18, 2025

Feb 17, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat

Feb 17, 2025

Feb 17, 2025

Vaxcyte SVP Mikhail Eydelman sells $450k in stock - MSN

Feb 17, 2025

Feb 15, 2025

Vaxcyte's (PCVX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Feb 15, 2025

Feb 13, 2025

WCM Investment Management LLC Sells 68,753 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Feb 13, 2025

Feb 12, 2025

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewswire

Feb 12, 2025

Feb 12, 2025

Vaxcyte, Inc. to Announce Q4 and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq

Feb 12, 2025

Feb 12, 2025

Vaxcyte Sets Stage for Major Q4 Revelations: Vaccine Innovation Updates & Financial Deep-Dive Coming - StockTitan

Feb 12, 2025

Feb 12, 2025

abrdn plc Buys 141,994 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Feb 12, 2025

Feb 11, 2025

Vaxcyte COO Jim Wassil sells $689,790 in stock - MSN

Feb 11, 2025

Feb 10, 2025

Calamos Advisors LLC Lowers Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Feb 10, 2025

Feb 09, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) COO Sells $689,760.00 in Stock - MarketBeat

Feb 09, 2025

Feb 09, 2025

Vaxcyte advances to final stage in infant vaccine study - MSN

Feb 09, 2025

Feb 08, 2025

Why Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Feb 08, 2025

Feb 07, 2025

Jennison Associates LLC Buys 9,121 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Feb 07, 2025

Feb 07, 2025

12 Best Healthcare Stocks to Buy According to Analysts - Insider Monkey

Feb 07, 2025

Feb 07, 2025

Vaxcyte SVP Mikhail Eydelman sells $450k in stock By Investing.com - Investing.com Nigeria

Feb 07, 2025

Feb 07, 2025

Vaxcyte’s Promising Pipeline and Growth Potential Justifies Buy Rating - TipRanks

Feb 07, 2025

Feb 06, 2025

Vaxcyte advances to final stage in infant vaccine study By Investing.com - Investing.com Australia

Feb 06, 2025

Feb 06, 2025

Vaxcyte advances second stage of Phase 2 study evaluating VAX-31 - Yahoo Finance

Feb 06, 2025

Feb 06, 2025

Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants - Clinical Trials Arena

Feb 06, 2025

Feb 06, 2025

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study - GlobeNewswire

Feb 06, 2025

Feb 05, 2025

Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage - Marketscreener.com

Feb 05, 2025

Feb 05, 2025

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants - The Manila Times

Feb 05, 2025